Remove 2004 Remove Computational Chemistry Remove Pharmaceuticals
article thumbnail

500 – and counting!

Sygnature Discovery

When DMPK scientist Lynette Ongeri joined Sygnature this month, she unknowingly helped us reach a landmark we couldn’t be prouder of… Sygnature Discovery – or Sygnature Chemical Services Ltd, as it was known then – opened its doors in 2004 with five colleagues. Back to Lynette, though.

article thumbnail

How the AI revolution can accelerate early drug discovery

Drug Target Review

Training AI/ML tools to predict results of otherwise complex and time-consuming calculations is gaining traction in pharmaceutical R&D. To really benefit from AI, the pharmaceutical industry must be more open to data sharing. Matthew subsequently put his computational chemistry skills to use in the defence sector.

Drugs 105
article thumbnail

Sygnature Discovery accelerates global growth with major North American acquisition

Sygnature Discovery

Founded in 2011, NuChem Sciences delivers expert integrated and standalone discovery solutions across medicinal, synthetic, scale-up, process and computational chemistry, as well as DMPK, in vitro biology and in vivo pharmacology.